Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual Transmission.
Cornelisse VJ, Traeger MW, Wright EJ, Murphy D, Stoové M, Hellard M, Sacks-Davis R, Asselin J, Fairley CK, Doyle J, Sasadeusz J
The Presence or Absence of Symptoms Among Cases of Urethral Gonorrhoea Occurring in a Cohort of Men Taking Human Immunodeficiency Virus Pre-exposure Prophylaxis in the PrEPX Study.
Donovan LC, Fairley CK, Aung ET, Traeger MW, Wright EJ, Stoové MA, Chow EPF
The Potential Impact of a Gel-Based Point-of-Sex Intervention in Reducing Gonorrhea Incidence Among Gay and Bisexual Men: A Modeling Study.
Traeger MW, Tidhar T, Holt M, Williams C, Wright EJ, Stoové MA, Scott N, Hellard ME
Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia.
Ryan KE, Asselin J, Fairley CK, Armishaw J, Lal L, Nguyen L, Murphy D, Traeger M, Hellard M, Hoy J, Stoové M, Wright E, PrEPX Study team
Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
Cornelisse VJ, Fairley CK, Stoove M, Asselin J, Chow EPF, Price B, Roth NJ, Willcox J, Tee BK, Penn M, Chang CC, Armishaw J, Forgan-Smith G, Wright EJ, PrEPX Study Team
Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis.
Lal L, Ryan K, Liu IY, Price B, Lockwood T, Aguirre I, Slobodian P, Lam A, Vassan M, Lim K, Silverii J, Tesoriero J, Phu J, Lim W, Naidoo B, Russell N, Rundle M, Sewell R, Cooper C, Hardman A, Quinn M, Mak A, Wright EJ